Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00596154
What this trial is testing

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Who this might be right for
CNS LymphomaCNS Brain CancerNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 33
Not applicableActive Not RecruitingNCT06170372
What this trial is testing

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

Who this might be right for
Nosocomial PneumoniaCommunity-acquired Pneumonia
Tomsk National Research Medical Center of the Russian Academy of Sciences 200
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Study completedNCT00340704
What this trial is testing

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Who this might be right for
Bladder, Neurogenic
Boehringer Ingelheim 143
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Testing effectiveness (Phase 2)Study completedNCT03788291
What this trial is testing

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Rochester 39
Early research (Phase 1)Study completedNCT05531097
What this trial is testing

Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C

Who this might be right for
HealthyElevated LDL-C
Haisco Pharmaceutical Group Co., Ltd. 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232
What this trial is testing

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 90
Testing effectiveness (Phase 2)Study completedNCT00556998
What this trial is testing

A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

Who this might be right for
Pharmacokinetics
Pfizer 26
Early research (Phase 1)Looking for participantsNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT01077401
What this trial is testing

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

Who this might be right for
Diabetic Macular Edema
Johns Hopkins University 152
Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Post-approval studies (Phase 4)Study completedNCT00334412
What this trial is testing

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis
Gilead Sciences 30
Post-approval studies (Phase 4)WithdrawnNCT01577199
What this trial is testing

RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders

Who this might be right for
Infertility
Weill Medical College of Cornell University
Not applicableStudy completedNCT03388463
What this trial is testing

Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.

Who this might be right for
Critical Illness
Menoufia University 110
Early research (Phase 1)Study completedNCT01949363
What this trial is testing

The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study

Who this might be right for
Gonorrhoea
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00002509
What this trial is testing

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer

Who this might be right for
Breast Cancer
Temple University
Large-scale testing (Phase 3)Study completedNCT01138657
What this trial is testing

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

Who this might be right for
Uveitis
AbbVie (prior sponsor, Abbott) 239
Post-approval studies (Phase 4)Study completedNCT00171899
What this trial is testing

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 80
Next Page